Core Insights - Bath & Body Works reported a slight decline in Q3 2025 sales and profits, while also trimming its full-year outlook and introducing a new multi-year strategic plan [1][5] Financial Performance - For Q3 2025, net sales were $1.59 billion, down 1% from $1.6 billion in Q3 2024 [1] - Earnings per diluted share decreased to $0.37 from $0.49 year-over-year [1] - Operating income fell to $161 million from $218 million, and net income declined to $77 million from $106 million in the same quarter of the previous year [2] - The reported figures included an $8 million pre-tax gain from the sale of a non-core asset [2] Future Guidance - For Q4 2025, net sales are expected to decline in the high single-digit range compared to $2.78 billion in Q4 2024 [2] - Q4 2025 earnings per diluted share are forecasted to be at least $1.7, down from $2.09 in Q4 2024 [2] - The full-year 2025 guidance has been revised to expect net sales to decline in the low single digits, compared to previous growth expectations of 1.5% to 2.7% against fiscal 2024 revenue of $7.3 billion [4] - Full-year 2025 earnings per diluted share are now projected to be at least $2.83, down from $3.61 in fiscal 2024 [4] - The company anticipates generating approximately $650 million in free cash flow for the full year [4] Strategic Initiatives - The CEO indicated that the third-quarter results were below expectations, prompting a lowered outlook for the remainder of the year due to current business trends and macro consumer pressures [5] - Bath & Body Works introduced a new strategic framework called the "Consumer First Formula," aimed at supporting long-term growth [6] - The first priority of the new strategy focuses on reinforcing product capabilities, with an emphasis on innovation in key categories such as body care, home fragrance, soaps, and sanitizers [7]